Athanasiou E, Papageorgiou S, Dafni M, Dafni M, Kelesis I, Vasileiou M
Curr Med Chem. 2024; 32(2):214-237.
PMID: 38369709
DOI: 10.2174/0109298673278897231229121524.
Singla R, Sharma P, Dubey A, Gundamaraju R, Kumar D, Kumar S
Front Pharmacol. 2021; 12:732266.
PMID: 34737700
PMC: 8560712.
DOI: 10.3389/fphar.2021.732266.
Azizi A, Mumin N, Shafqat N
F1000Res. 2021; 10:221.
PMID: 34316358
PMC: 8276191.
DOI: 10.12688/f1000research.51066.3.
DArrigo G, Gianquinto E, Rossetti G, Cruciani G, Lorenzetti S, Spyrakis F
Molecules. 2021; 26(6).
PMID: 33799482
PMC: 8001607.
DOI: 10.3390/molecules26061613.
Pabich M, Materska M
Nutrients. 2019; 11(7).
PMID: 31330799
PMC: 6683102.
DOI: 10.3390/nu11071660.
Genistein increases estrogen receptor beta expression in prostate cancer via reducing its promoter methylation.
Mahmoud A, Al-Alem U, Ali M, Bosland M
J Steroid Biochem Mol Biol. 2015; 152:62-75.
PMID: 25931004
PMC: 4501888.
DOI: 10.1016/j.jsbmb.2015.04.018.
Impact of soy isoflavones on the epigenome in cancer prevention.
Pudenz M, Roth K, Gerhauser C
Nutrients. 2014; 6(10):4218-72.
PMID: 25322458
PMC: 4210915.
DOI: 10.3390/nu6104218.
Isolation, bioactivity, and production of ortho-hydroxydaidzein and ortho-hydroxygenistein.
Chang T
Int J Mol Sci. 2014; 15(4):5699-716.
PMID: 24705463
PMC: 4013590.
DOI: 10.3390/ijms15045699.
Soya and isoflavone intakes associated with reduced risk of oesophageal cancer in north-west China.
Tang L, Lee A, Xu F, Zhang T, Lei J, Binns C
Public Health Nutr. 2014; 18(1):130-4.
PMID: 24674768
PMC: 10271313.
DOI: 10.1017/S1368980013003443.
Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells.
Hirata H, Hinoda Y, Shahryari V, Deng G, Tanaka Y, Tabatabai Z
Br J Cancer. 2014; 110(6):1645-54.
PMID: 24504368
PMC: 3960620.
DOI: 10.1038/bjc.2014.48.
Differential effects of genistein on prostate cancer cells depend on mutational status of the androgen receptor.
Mahmoud A, Zhu T, Parray A, Siddique H, Yang W, Saleem M
PLoS One. 2013; 8(10):e78479.
PMID: 24167630
PMC: 3805529.
DOI: 10.1371/journal.pone.0078479.
Aggressive prostate cancer is prevented in ERαKO mice and stimulated in ERβKO TRAMP mice.
Slusarz A, Jackson G, Day J, Shenouda N, Bogener J, Browning J
Endocrinology. 2012; 153(9):4160-70.
PMID: 22753646
PMC: 3423626.
DOI: 10.1210/en.2012-1030.
Dietary agents in cancer prevention: an immunological perspective.
Zheng Y, Viswanathan B, Kesarwani P, Mehrotra S
Photochem Photobiol. 2012; 88(5):1083-98.
PMID: 22372381
PMC: 3595550.
DOI: 10.1111/j.1751-1097.2012.01128.x.
Does equol production determine soy endocrine effects?.
Shor D, Sathyapalan T, Atkin S, Thatcher N
Eur J Nutr. 2012; 51(4):389-98.
PMID: 22366740
DOI: 10.1007/s00394-012-0331-7.
A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients.
Messing E, Gee J, Saltzstein D, Kim K, diSantAgnese A, Kolesar J
Cancer Prev Res (Phila). 2012; 5(4):621-30.
PMID: 22293631
PMC: 3324663.
DOI: 10.1158/1940-6207.CAPR-11-0455.
Risk factors for the onset of prostatic cancer: age, location, and behavioral correlates.
Leitzmann M, Rohrmann S
Clin Epidemiol. 2012; 4:1-11.
PMID: 22291478
PMC: 3490374.
DOI: 10.2147/CLEP.S16747.
Bioavailability of phytochemical constituents from a novel soy fortified lycopene rich tomato juice developed for targeted cancer prevention trials.
Bohn T, Blackwood M, Francis D, Tian Q, Schwartz S, Clinton S
Nutr Cancer. 2011; 65(6):919-29.
PMID: 22098224
PMC: 3850031.
DOI: 10.1080/01635581.2011.630156.
Soy content of basal diets determines the effects of supplemental selenium in male mice.
Quiner T, Nakken H, Mason B, Lephart E, Hancock C, Christensen M
J Nutr. 2011; 141(12):2159-65.
PMID: 22031663
PMC: 3223873.
DOI: 10.3945/jn.111.146498.
Estrogens and prostate cancer: etiology, mediators, prevention, and management.
Ho S, Lee M, Lam H, Leung Y
Endocrinol Metab Clin North Am. 2011; 40(3):591-614, ix.
PMID: 21889723
PMC: 3167093.
DOI: 10.1016/j.ecl.2011.05.002.
7,3',4'-Trihydroxyisoflavone inhibits epidermal growth factor-induced proliferation and transformation of JB6 P+ mouse epidermal cells by suppressing cyclin-dependent kinases and phosphatidylinositol 3-kinase.
Lee D, Lee K, Song N, Seo S, Heo Y, Kang N
J Biol Chem. 2010; 285(28):21458-66.
PMID: 20444693
PMC: 2898435.
DOI: 10.1074/jbc.M109.094797.